Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 331.55
+28.05 (9.24%)
At close: Dec 23, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.47 trillion as of December 26, 2025. Its market cap has decreased by -56.99% in one year.
Market Cap
1.47T
Enterprise Value
1.54T
Revenue
315.60B
Ranking
n/a
PE Ratio
14.21
Stock Price
331.55
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.47T, an increase of 3,102.53%. That is a compound annual growth rate of 12.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 1.47T | -46.86% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | 986.61B | 8.50% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 130.78B |
| Coloplast | 122.33B |
| ALK-Abelló | 50.34B |
| Demant | 45.59B |
| H. Lundbeck | 41.13B |
| Zealand Pharma | 33.95B |
| Ambu A/S | 23.39B |
| GN Store Nord | 15.18B |